Synaptic imbalance and increased inhibition impair motor function in SMA
Science Advances · 2025
DOI: 10.1126/sciadv.adt4126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Emily V Fletcher und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Motor Neurons, Synapses, Synaptic Transmission. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIAAA NIH HHS.
Abstract (Originalsprache)
Movement is executed through balanced excitation-inhibition in spinal motor circuits. Short-term perturbations in one type of neurotransmission are homeostatically counteracted by the opposing type, but prolonged excitation-inhibition imbalance causes dysfunction at both single neuron and circuit levels. However, whether dysfunction in one or both types of neurotransmission leads to pathogenicity in neurodegenerative diseases characterized by select synaptic deficits is not known. Here, we used functional, morphological, and viral-mediated approaches to uncover the pathogenic contribution of unbalanced excitation-inhibition in a mouse model of spinal muscular atrophy (SMA). We show that vulnerable SMA motor circuits fail to respond homeostatically to reduced excitation and instead increase inhibition. This imposes an excessive burden on motor neurons and further restricts their recruitment. Reducing inhibition genetically or pharmacologically improves neuronal function and motor behavior in SMA mice. Thus, the disruption of excitation-inhibition homeostasis is a major maladaptive mechanism that diminishes the capacity of premotor commands to recruit motor neurons and elicit muscle contractions in SMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.
- Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA.
- Department of Cell Biology, Emory University, Atlanta, GA 30322, USA.
- Department of Pharmacology, Center of Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
- Department of Neurology, Columbia University, New York, NY 10032, USA.
ORCID-Profile: Emily V Fletcher, Joshua I Chalif, Travis M Rotterman, John G Pagiazitis, Meaghan Van Alstyne, Danny Florez-Paz, Livio Pellizzoni, Francisco J Alvarez, George Z Mentis
Förderung
- NINDS NIH HHS
- NIAAA NIH HHS
Zitieren
APA
Fletcher, E. V., Chalif, J. I., Rotterman, T. M., Pagiazitis, J. G., Van Alstyne, M., Sivakumar, N., Florez-Paz, D., Rabinowitz, J. E., Pellizzoni, L., Alvarez, F. J., & Mentis, G. Z. (2025). Synaptic imbalance and increased inhibition impair motor function in SMA. Science Advances. https://doi.org/10.1126/sciadv.adt4126
Vancouver
Fletcher EV, Chalif JI, Rotterman TM, Pagiazitis JG, Van Alstyne M, Sivakumar N, et al. Synaptic imbalance and increased inhibition impair motor function in SMA. Science Advances. 2025. doi:10.1126/sciadv.adt4126
BibTeX
@article{Fletcher2025,
author = {Fletcher, Emily V and Chalif, Joshua I and Rotterman, Travis M and Pagiazitis, John G and Van Alstyne, Meaghan and Sivakumar, Nandhini and Florez-Paz, Danny and Rabinowitz, Joseph E and Pellizzoni, Livio and Alvarez, Francisco J and Mentis, George Z},
title = {Synaptic imbalance and increased inhibition impair motor function in SMA},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adt4126}
}
EUVIMED